Compare CRVO & HMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVO | HMR |
|---|---|---|
| Founded | 2001 | 1984 |
| Country | United States | Greece |
| Employees | N/A | 57 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 49.3M |
| IPO Year | 2011 | N/A |
| Metric | CRVO | HMR |
|---|---|---|
| Price | $3.92 | $0.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $23.00 | $5.00 |
| AVG Volume (30 Days) | ★ 43.9K | 36.8K |
| Earning Date | 05-11-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,006,510.00 | N/A |
| Revenue This Year | N/A | $64.04 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.51 | $0.76 |
| 52 Week High | $13.13 | $3.45 |
| Indicator | CRVO | HMR |
|---|---|---|
| Relative Strength Index (RSI) | 41.98 | 50.01 |
| Support Level | $3.55 | $0.77 |
| Resistance Level | $4.41 | $0.96 |
| Average True Range (ATR) | 0.31 | 0.05 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 35.56 | 63.25 |
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.